… of treatment persistence with dabigatran or rivaroxaban versus vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a competing risk analysis in the …

G Maura, C Billionnet, F Alla, JJ Gagne… - … : The Journal of …, 2018 - Wiley Online Library
… of stroke in patients with non-valvular atrial fibrillation (nv-AF).1-3 … once (rivaroxaban,
apixaban) or twice (dabigatran) daily … Patients initiating low-dose dabigatran or rivaroxaban were …

… and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study

YC Lin, BL Chen, CM Shih, FY Lin, CW Chen, CY Hsu… - PLoS …, 2021 - journals.plos.org
… safety of apixaban with warfarin for stroke prevention in patients with … bleeding rates associated
with rivaroxaban, dabigatran, and … First, the data source was insurance claims, and thus, …

Major bleeding complications and persistence with oral anticoagulation in nonvalvular atrial fibrillation: contemporary findings in real‐life Danish patients

M Lamberts, L Staerk, JB Olesen… - Journal of the …, 2017 - Am Heart Assoc
atrial fibrillation patients, apixaban had a lower adjusted major bleeding risk compared with
rivaroxaban, dabigatran, … In these trials, apixaban and lowdose dabigatran had lower risk of …

Real-world comparisons of reduced-dose non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation: a systematic review and meta-analysis

X Wang, L Fang, B Liu, Y Zheng, J Zeng - Heart Failure Reviews, 2020 - Springer
… outcomes in low-dose NOACs (dabigatran, rivaroxaban, and … Xa inhibitors OR dabigatran
OR rivaroxaban OR apixaban OR … with decreased risks of thromboembolic and bleeding events…

[HTML][HTML] Contemporary trend of reduced-dose non-vitamin K anticoagulants in Japanese patients with atrial fibrillation: A cross-sectional analysis of a multicenter …

T Ono, N Ikemura, T Kimura, I Ueda, H Tanaka… - Journal of …, 2019 - Elsevier
… stroke in non-valvular atrial fibrillation (NVAF) patients. … with CrCl 15–49 ml/min; apixaban
5 mg/day for patients with … this study, we defined patients with 220 mg/day of dabigatran

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill, J Hippisley-Cox - bmj, 2018 - bmj.com
… gastrointestinal bleeding compared with warfarin. Rivaroxaban and low dose apixaban
were… mg for dabigatran, 20 mg for rivaroxaban, and 10 mg for apixaban. In the subcohort with …

[HTML][HTML] Low-dose NOACs versus standard-dose NOACs or warfarin on efficacy and safety in Asian patients with NVAF: a meta-analysis

Z Li, Y Zheng, D Li, X Wang, S Cheng… - Anatolian Journal of …, 2022 - ncbi.nlm.nih.gov
… for Asian patients with non-valvular atrial fibrillation. We aimed … Low-dose NOACs were
defined as dabigatran 110 mg bid, … together even though rivaroxaban, apixaban, and edoxaban …

Comparative effectiveness and safety of low-dose oral anticoagulants in patients with atrial fibrillation

S Perreault, A Dragomir, R Cote, A Lenglet… - Frontiers in …, 2022 - frontiersin.org
… comparing low-dose dabigatran with low-dose rivaroxaban, … For low-dose rivaroxaban vs
apixaban, we did not observe a … RCT in older Japanese patients with non-valvular AF (where a …

Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation

M Hori, SJ Connolly, J Zhu, LS Liu, CP Lau, P Pais… - Stroke, 2013 - Am Heart Assoc
… This is reflected in Japanese guidelines for anticoagulation, … that dabigatran reduced the risk
of bleeding outcomes more in … This strongly suggests Asian propensity to bleed on warfarin. …

… non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world …

Y Waranugraha, A Rizal, MFR Syaban… - The Egyptian Heart …, 2021 - Springer
apixaban, and low-dose dabigatran were related to lower bleeding rates [11,12,13]. However,
… , edoxaban, rivaroxaban, or warfarin from 34 real-world studies were involved in our meta-…